Overview
No overview information available.
Indication
No indication information available.
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|
No clinical trials found
No clinical trials found for this drug
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| Athenex Pharmaceutical Division, LLC. | 70860-202 | INTRAVENOUS | 100 mg in 4.2 mL | 11/17/2023 | |
| Accord Healthcare Inc. | 16729-230 | INTRAVENOUS | 500 mg in 20 mL | 3/27/2024 | |
| Eugia US LLC | 55150-383 | INTRAVENOUS | 1000 mg in 40 mL | 7/27/2023 | |
| SHILPA MEDICARE LIMITED | 63759-3048 | INTRAVENOUS | 100 mg in 10 mL | 6/3/2023 | |
| Qilu Pharmaceutical Co., Ltd. | 67184-0503 | INTRAVENOUS | 100 mg in 4 mL | 6/1/2022 | |
| Athenex Pharmaceutical Division, LLC. | 70860-203 | INTRAVENOUS | 500 mg in 20 mL | 11/17/2023 | |
| BluePoint Laboratories | 68001-536 | INTRAVENOUS | 500 mg in 20 mL | 9/5/2023 | |
| Ingenus Pharmaceuticals, LLC | 50742-341 | INTRAVENOUS | 500 mg in 20 mL | 5/16/2022 | |
| Qilu Pharmaceutical Co., Ltd. | 67184-0504 | INTRAVENOUS | 500 mg in 20 mL | 6/1/2022 | |
| BluePoint Laboratories | 68001-535 | INTRAVENOUS | 100 mg in 4 mL | 9/5/2023 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
Authorised | 11/19/2015 | ||
Authorised | 11/19/2015 | ||
Withdrawn | 12/2/2015 | ||
Authorised | 1/18/2016 | ||
Withdrawn | 9/18/2015 |
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| DBL PEMETREXED (AS DISODIUM) POWDER FOR INJECTION 100MG | N/A | N/A | N/A | 8/13/2014 | |
| MYTREX POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 500MG | N/A | N/A | N/A | 4/9/2025 | |
| ACCORD PEMETREXED POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 100MG | N/A | i & c (hong kong) limited | N/A | N/A | 3/10/2017 |
TGA Drug Approvals
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
|---|---|---|---|---|---|
| No Health Canada approvals found for this drug. | |||||
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
|---|---|---|---|---|---|
| No CIMA AEMPS (Spain) approvals found for this drug. | |||||
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Philippines FDA approvals found for this drug. | |||||
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Saudi SFDA approvals found for this drug. | |||||
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Malaysia NPRA approvals found for this drug. | |||||
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
|---|---|---|---|---|---|
| No UK EMC drug information found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.